Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment

doi:10.1001/jama.300.14.1665

JAMA. Author manuscript; available in PMC 2010 April 13.

Published in final edited form as:

JAMA. 2008 October 8; 300(14): 1665–1673.

doi: 10.1001/jama.300.14.1665

PMCID: PMC2853806

NIHMSID: NIHMS191663

Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment

Alexi A. Wright, MD,^1,² Baohui Zhang, MS,² Alaka Ray, MD,^2,³ Jennifer W. Mack, MD, MPH,^4,⁵ Elizabeth Trice, MD, PhD,^1,² Tracy Balboni, MD, MPH,^2,⁶ Susan L. Mitchell, MD,^7,⁸ Vicki A. Jackson, MD,^3,⁸ Susan D. Block, MD,^2,^9,¹⁰ Paul K. Maciejewski,¹¹ and Holly G. Prigerson, PhD^2,^9,¹⁰

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA

²Center for Psycho-Oncology and Palliative Care Research, Dana-Farber Cancer Institute, Boston, MA 02115, USA

³Massachusetts General Hospital, Boston, MA 02114, USA.

⁴Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA

⁵Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

⁶Harvard Radiation Oncology Program

⁷Institute for Aging Research, Hebrew SeniorLife, Roslindale, MA 02131, USA

⁸Beth Israel Deaconess Medical Center, Boston, MA 02115, USA

⁹Harvard Medical School Center for Palliative Care, Boston, MA 02115, USA

¹⁰Department of Psychiatry, Brigham and Women’s Hospital, Boston, MA 02115, USA

¹¹Department of Psychiatry, Women’s Health Research, and Magnetic Resonance Research Center, Yale University School of Medicine, New Haven, CT, 06510 USA

Corresponding Author: Alexi A. Wright, MD, Department of Medical Oncology and Center for Psycho-Oncology and Palliative Care Research, Dana-Farber Cancer Institute, 550 Shields Warren, 44 Binney Street, Boston, MA 02115. Phone: (617) 632-6863, Fax: (617) 582-8017, Email: awright2/at/partners.org,alexiwright/at/gmail.com.

>Author Contributions: Dr. Prigerson, Dr. Wright and Ms. Zhang had full access to all of the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis.

Dr. Wright and Ms. Zhang contributed equally as primary coauthors.

The publisher's final edited version of this article is available at JAMA

See other articles in PMC that cite the published article.

Abstract

Context

Talking about death can be difficult. Without evidence that end-of-life (EOL) discussions improve patient outcomes, physicians must balance their desire to honor patient autonomy against a concern that EOL discussions may inflict psychological harm.

Objective

To determine whether EOL discussions with physicians are associated with fewer aggressive interventions.

Design, Setting, Participants

A United States multi-site, prospective, longitudinal cohort study of advanced cancer patients and their informal caregivers (n=332 dyads), September 2002-February 2008. Patients were followed from enrollment to death a median of 4.4 months later. Bereaved caregivers’ psychiatric illness and quality of life (QoL) was assessed a median 6.5 months later.

Main Outcome Measures

The primary outcome were aggressive medical care (e.g., ventilation, resuscitation) and hospice in the final week of life. Secondary outcomes included patients’ mental health and caregivers’ bereavement adjustment.

Results

123 of 332 (37.0%) patients reported EOL discussions before baseline. EOL discussions were not associated with higher rates of Major Depressive Disorder (8.3% vs. 5.8; AOR 1.33, 95% CI 0.54-3.32), or more “worry” (6.5 vs. 7.0; p=0.19)). After propensity-score weighted adjustment, EOL discussions were associated with lower rates of ventilation (1.6% vs. 11.0%; AOR 0.26, 95% CI 0.08-0.83), resuscitation (0.8% vs. 6.7%; AOR 0.16, 95% CI 0.03-0.80), ICU admission (4.1 vs. 12.4%; AOR 0.35, 95% CI 0.14-0.90), and earlier hospice enrollment (65.6% vs. 44.5%; AOR 1.58, 95% CI 1.04-2.63). In adjusted analyses, more aggressive medical care was associated with worse patient QoL (6.4 vs. 4.6; F=3.60, p=0.01) and higher risk for Major Depressive Disorder in bereaved caregivers (AOR 3.37, 95% CI 1.12-10.13), while longer hospice stays were associated with better patient QoL (5.6 vs. 6.9; F=3.70, p=0.01). Better patient QoL was associated with better caregiver QoL at follow-up (β=0.20; p=0.001).

Conclusion

EOL discussions are associated with less aggressive medical care near death and earlier hospice referrals. Aggressive care is associated with worse patient QoL and worse bereavement adjustment.

Keywords: cancer, terminal illness, end-of-life care, communication, prognosis, depression, hospice, palliative care, treatment preferences

INTRODUCTION

End-of-life (EOL) discussions offer patients the opportunity to define their goals and expectations for the medical care that they want to receive near death. But, these discussions also mean confronting the limitations of medical treatments and the reality that life is finite, both of which may cause psychological distress.¹ Studies suggest that doctors and patients are ambivalent about talking about death, and often avoid EOL conversations.²^-¹³ To date, however, research has not examined whether these discussions are associated with patients’ psychological distress or medical care near death. Without this information doctors cannot weigh the risks and benefits of EOL discussions.

A decade ago Weeks et al.¹⁴ demonstrated that advanced cancer patients who preferred life-extending therapy were often overly optimistic about their chances of survival. These results suggested that EOL discussions might reduce the aggressiveness of medical care near death by making patients more realistic about the benefits of intensive therapies. Consistent with this, a small study showed that EOL conversations significantly influenced patients’ understanding that their illness was terminal and that this, in turn, was associated with increased integration of hospice.¹⁵ Another study demonstrated that patients who wanted to avoid cardiopulmonary resuscitation and discussed their preferences with physicians were more likely to have do-not-resuscitate orders.¹⁶ Others have shown that hospice is associated with better quality of life (QoL) near death,¹⁷ and reductions in bereaved caregivers’ risk of developing Major Depressive Disorder.¹⁸ To date, however, research has not examined whether EOL discussions are associated with patients’ medical care in the final week of life, or whether the medical care received at the EOL is correlated with differences in patients’ QoL near death or caregivers’ bereavement outcomes.

The primary aim of this prospective, longitudinal cohort study was to examine the associations between EOL discussions with physicians and the medical care that terminally ill cancer patients receive near death. Our a priori hypothesis was that EOL discussions would be associated with less aggressive medical care and earlier integration of hospice. Our secondary aims were to examine the associations between EOL discussions and patients’ psychological distress, QoL near death, and caregivers’ bereavement outcomes. We hypothesized that EOL discussions would be associated with greater psychological distress. Although we did not expect patients’ QoL near death to be directly influenced by EOL discussions reported at baseline, we did expect that patients’ QoL would be influenced by the medical care that they actually received near death. We also hypothesized that patients’ EOL experiences (i.e., their medical care and QoL) would affect the surviving caregivers’ bereavement adjustment.

METHODS

Study sample

Coping with Cancer (CwC) was an NCI- and NIMH-funded prospective, longitudinal, multi-site cohort study of terminally ill cancer patients and their informal caregivers (e.g., spouse or adult child) followed through bereavement. CwC sought to examine how psychosocial factors influencing patients’ care and their caregivers’ bereavement adjustment.

Patients were recruited from September 1, 2002 to February 28, 2008 from seven different outpatient sites: Yale Cancer Center (New Haven, CT), the Veterans Affairs Connecticut Healthcare System Comprehensive Cancer Clinics (West Haven, CT), the Parkland Hospital Palliative Care Service (Dallas, TX), Simmons Comprehensive Cancer Center (Dallas, TX), Massachusetts General Hospital (Boston, MA), Dana-Farber Cancer Institute (Boston, MA), and New Hampshire Oncology-Hematology (Hookset, NH). Approval was obtained from the human subjects committees of all participating centers; all enrolled patients provided written informed consent.

Eligibility criteria included: diagnosis of advanced cancer (presence of distant metastases and disease refractory to first-line chemotherapy; age ≤ 20 years, presence of an informal caregiver; and clinic staff and interviewer assessment that the patient had adequate stamina to complete the interview. Patient-caregiver dyads in which either the patient or caregiver refused to participate, met criteria for dementia or delirium (by neuro-behavioral cognitive status exam), or did not speak either English or Spanish were excluded.

Of the 917 eligible patients, 638 patients (69.6%) were consented and enrolled in the larger study. The most common reasons for nonparticipation (N=279) included “not interested” (N=120), “other” (N=69), or “caregiver refuses” (N=37). There were no differences in the socio-demographic characteristics between the participants and non-participants, except that participants were more likely to be Hispanic (11.8% vs. 5.7%, p=0.006). For the present analysis, we restricted our sample to the 332 patients who died to examine the medical care that patients received in the final week of life. The deceased cohort did not differ significantly (p<0.05) by cancer type, psychological distress, or rates of psychiatric disorders. However, as expected, this cohort was more debilitated (e.g., had worse performance status and higher symptom burden) and more likely to have characteristics associated with lower socioeconomic status (e.g., be younger, female, uninsured, and identify as a member of an ethnic minority group).¹⁹^,²⁰

Protocol and Measures

Research staff at each site participated in a two-day training session covering the study protocol, medical chart extraction, and techniques for interviewing terminally ill patients and their families. Participants were identified from outpatient clinic. All interviews were conducted in English or Spanish. Patient interviews took an average of 30-45 minutes to complete; caregiver interviews typically lasted 60-75 minutes. Patients and caregivers received $25 as compensation. Upon study enrollment, research staff interviewed the patient and caregiver separately, reviewed the medical record, and confirmed each patient’s diagnosis, treatment, and performance status with the physician.

In the baseline interview patients were asked “Have you and your doctor discussed any particular wishes you have about the care you would want to receive if you were dying?” Responses were coded as “1=yes” and “2=no.” Psychosocial factors identified in the literature as important predictors of EOL care were recorded, including patients’ treatment preferences,¹⁴ advance care planning, acknowledgement that their illness was terminal,¹⁵^,²¹ religiousness (patients who reported religion was “very important” were coded as “religious”),²² and the doctor-patient relationship.²³ A close doctor-patient relationship was defined as one where patients trusted and respected their doctor, felt respected and “seen as a whole person,” and were very comfortable asking questions about their care. Socio-demographic characteristics were recorded as reported by the patient. Race/ethnicity was analyzed as a potential determinant of EOL medical care because advanced cancer patients of different racial/ethnic groups have been found to vary in their treatment preferences, advance care planning, and healthcare utilization.²⁴^-²⁷ Race/ethnicity was determined by patient self-report in response to the open-ended question: “What race or ethnicity do you consider yourself to be?” Patients who identified themselves as Hispanic were analyzed as such, regardless of whether they reported White or Black status. Mental health measures included: the Structured Clinical Interview for Diagnostic and Statistical Manual-DSM-IV (SCID),²⁸^,²⁹ the Endicott Scale,³⁰ and McGill Quality of Life (MQoL) psychological subscale.³¹ Patients’ functional status and comorbid medical conditions were measured with the Karnofsky score³² and the Charlson Comorbidity Index, respectively.³³ QoL was assessed with the MQoL Index’s physical health, symptom, and social support subscales.³¹ Caregiver interviews included self-reported socio-demographic characteristics and baseline measures of physical and mental health measures, including the SCID and the Medical Outcomes Study 36-item Short Form Survey (MOS SF-36).³⁴

Research staff reviewed the list of study participants weekly with clinic staff at each site. Within two to three weeks of a participants’ death research staff reviewed the medical record to document medical care received. This included specific services that have been defined in the literature as indicators of aggressive medical care, including: admission to an intensive care unit, ventilation, resuscitation, chemotherapy, or use of a feeding tube near death.³⁵ In a post-mortem interview, research staff interviewed the formal/informal caregiver involved in the patients’ care during the final week of life to assess the patient’s QoL near death. Specifically, they asked: “In your opinion, how would you rate the overall quality of the patients’ death/last week of life?” Response items were arranged on a Likert scale from 0 “worst possible” to 10 “best possible.” Patients’ location of death and length of time in hospice was documented.

Bereaved caregivers were interviewed a median of 6.5 months after the patient’s death to assess their bereavement adjustment. We chose this point so that caregivers would be likely to be beyond a state of acute grief,³⁶ but close enough to the death to avoid introduction of recall bias. Interviewers repeated the SCID and MOS SF-36. Caregivers were also asked about their satisfaction and regrets about patients’ EOL care.

Statistical analysis

T-test, Cochran-Mantel-Haenszel, and χ² test statistics were used, as appropriate, to test for significant differences between patients who did or did not report EOL discussions with their physicians at baseline. A Cox proportional hazards model was performed to examine differences in survival between the two groups. A log-rank test was used to determine whether the groups differed significantly in survival. Item non-response rates were less than 10% for all study variables, except for a question that assessed patients’ preferences for life-extending therapy (11.6% responded “don’t know”). To preserve the study sample, missing data were imputed at the median value, except for patients’ preference for life-extending therapy which was imputed by the predicted value from a multivariable logistic regression model.

We used a propensity-score weighting technique to balance characteristics that differed significantly (p<0.10) between the two groups (i.e., recruitment site, Karnofsky score, Charlson Comorbidity Index, MQoL symptom subscale, survival, religiousness). Logistic regression models estimated the odds of reporting an EOL conversation as a function of these characteristics. The predicted probabilities of reporting an EOL conversation (propensity scores) were used to derive individual weights equal to the probability of belonging to the opposite group, making the weighted distribution of characteristics among participants in both groups balanced. ³⁷ Therefore weighted analyses adjusted for potential confounding from measured characteristics associated with EOL discussions. Propensity-score weighted logistic regression was used to estimate the effect of EOL discussions on binary outcomes (e.g., psychiatric disorders), while propensity-score weighted linear regression models estimated the effect of EOL discussions on continuous measures (e.g., QoL). Logistic regression models examining the effect of EOL discussion on medical care received in the last week of life were also adjusted for patients’ treatment preferences, desire for prognostic information, and terminal illness acknowledgement.

Multivariable relationships between patients’ QoL at the EOL and the intensity of medical services received were examined. Adjusted one-way ANOVA models tested the associations between patient QoL near death and the number of aggressive procedures as well as length of hospice stay, controlling for Karnofsky score and survival. The relationship between patients’ QoL near death, the number of aggressive procedures received in the last week of life, and the length of hospice stay was plotted.

Caregiver bereavement outcomes estimated the effects of patient medical care and QoL near death on the surviving caregiver’s likelihood of meeting criteria for psychiatric disorders, health-related QoL, and grief reactions (e.g., regret). In these models, baseline measures of each bereavement outcome (e.g., overall QoL) were included to estimate the effect of the death over and above caregiver baseline levels. Other confounding influences were included in the model if they changed the estimate of the main predictor by >10%, and were retained if they remained significant at a level of p<0.05 controlling for other confounders. Confounders considered included: socio-demographics characteristics (age, sex, race, education, and religion), kinship relationship, length of caregiving, source of report for patient QoL, and religiousness. Statistical analyses were performed with SAS version 9.1 (SAS Institute Inc, Cary, NC). We report two-sided p-values without adjustment for multiple comparisons.

RESULTS

Patient characteristics

The cohort consisted of 332 terminally ill cancer patients who died a median of 4.4 months after enrollment. The socio-demographic, clinical, and psychosocial characteristics of the cohort at baseline are described in Table 1. Overall, 123 of 332 (37.0%) patients reported having EOL discussions with their physicians at baseline.

Table 1

Participant Characteristics by End Of Life (EOL) Care Discussion with a Physician (N=332)

There were no associations between EOL discussions and patients’ self-reported socio-demographic characteristics (age, sex, race, marital status, education, insurance, or religion), cancer type, relationships with physicians, religiousness, or social support. There were, however, significant site differences with 61.5% of patients at New Hampshire Hematology Oncology reporting EOL conversations compared to 16.2% at Yale Cancer Center (p<0.001). Patients reporting discussions had lower performance status (59.5 vs. 65.7; p=0.003), higher symptom burden (5.0 vs. 5.6; p=0.02), and shorter survival times (95 vs. 154 days; p=0.002), compared to patients who did not.

Propensity-score weighting successfully adjusted for significant differences in the baseline characteristics of patients who reported EOL conversations and those who did not. After adjustment participants no longer differed by their Karnofsky score, symptom burden, survival time, recruitment site, or religiousness.

Caregiver characteristics

Caregivers’ socio-demographic characteristics were similar to those of the patients, except that they were significantly (p<0.05) younger (mean age: 51.2 vs. 57.9 years), more likely to be female (77.0% vs. 44.9%), and more highly educated (mean: 13.2 vs. 12.6 years). The caregiver-patient kinship relationships were: spouse (51.4%), adult child (24.0%), other relative (13.9%), friend (6.6%), and parent (4.2%). The median length of time spent caregiving prior to baseline was 11.5 months (interquartile range: 5.0-30.0 months).

Mental health, treatment preferences, and advance care planning

As shown in table 2, EOL discussions were not associated with patients feeling “depressed,” “sad,” “terrified,” “worried,” or meeting DSM-IV-criteria for a mental disorder in propensity-weighted analyses. Patients who reported EOL conversations were significantly (p≥0.001) more likely to accept that their illness was terminal (52.9% vs. 28.7%), prefer medical treatment focused on relieving pain and discomfort over life-extending therapies (85.4% vs. 70.0%), and complete a do-not-resuscitate order (63.0% vs. 28.5%).

Table 2

Associations Between Advanced Cancer Patients’ End-of-Life Discussions, Mental Health, Terminal Illness Acceptance, Treatment Preferences, and Planning

Medical care at the end-of-life

In propensity-score weighted analyses, adjusted for patients’ desire for prognostic information, terminal illness acceptance and treatment preferences, patients who reported EOL conversations with their physicians at baseline received significantly fewer aggressive medical interventions near death. As shown in table 3, patients who reported EOL discussions were less likely to receive mechanical ventilation (1.6% vs. 11.0%; p=0.02), undergo resuscitation (0.8% vs. 6.7%; p=0.03), or be admitted to the intensive care unit (4.1% vs. 12.4%; p=0.03). Patients reporting EOL discussions were more likely to be enrolled in outpatient hospice for more than one week (65.6% vs. 44.5%, p=0.03).

Table 3

Medical Care Received in the Last Week of Life by End of Life (EOL) Discussion (N=332)

Patients’ Quality of Life at EOL

Patients who received aggressive medical interventions had worse QoL in the final week of life. Patients’ QoL decreased with increasing numbers of aggressive medical therapies, even after adjusting for their severity of illness (see Figure 1). Patients who received no aggressive care had a mean QoL score of 6.4, while patients who received 3 or more therapies had a mean QoL score of 4.6 (F=3.61, df=3, p=0.01). The inverse was true for hospice care, where patients’ QoL improved the longer they were enrolled, except for patients who received less than one week of services. Patients who did not receive hospice had a mean QoL score of 5.6; those enrolled for one week or less had a QoL score of 5.6; and those enrolled for 2 months or more had QoL scores of 6.9 (F=4.04, df=3, p=0.008).

Figure 1

Results adjusted for illness severity, as measured by Karnofsky score and survival. Hospice length: 0=no hospice, 1=less than one week, 2=one to eight weeks, 3=more than eight weeks (F=4.04, df=3, p=0.008).

Bereavement Outcomes

In table 4, we display analyses that examined the associations between patients’ experience in the last week of life and caregivers’ bereavement adjustment, controlling for significant confounds (caregivers’ socio-demographics and baseline QoL). Caregivers of patients who received any aggressive care were at higher risk for developing a Major Depressive Disorder (AOR 3.37, 95% CI 1.12-10.13), experiencing regret (β=0.17; p=0.01), and feeling unprepared for the patient’s death (β=−0.30; p<0.001), compared to caregivers of patients who did not receive aggressive care. They also had worse QoL outcomes, including overall QoL (β=−0.15; p=0.004), self-reported health (β=−0.12; p=0.04), and increased role limitations (β=0.17; p=0.008).

Table 4

Associations Between Caregivers’ Outcomes and Patients’ EOL Care and Quality of Life (QoL) (N=202)

As illustrated in Figure 2, there was a direct relationship between patients’ QoL near death and their bereaved caregivers’ QoL at follow-up. High patient QoL was associated with better caregiver outcomes, including overall QoL (β=0.20; p=0.001), self-reported health (β=0.17, p=0.004), physical functioning (β=0.14, p=0.02), mental health (β=0.13, p=0.04), and improvements in self-rated change in health (AOR 1.17, 95% CI 1.05, 1.29). Caregivers of patients with high QoL felt better prepared for the death (β=0.23, p=0.002) and experienced less regret (β=−0.30, p<0.001) at follow-up.

DISCUSSION

Our results suggest that EOL discussions may have cascading benefits for patients and their caregivers. Despite physicians’ concerns that patients may suffer psychological harm due to EOL discussions,⁵^-⁷^,⁹ we found no evidence that they were significantly associated with increased emotional distress or psychiatric disorders. Instead, the worst outcomes were seen in patients who did not report EOL conversations. This group received significantly more aggressive medical care in their final week of life, which was associated with worse patient quality of life near death. In addition, their bereaved caregivers experienced worse quality of life, more regret, and were at higher risk for developing a Major Depressive Disorder a median of 6.5 months later.

On the other hand, patients who reported EOL discussions received less aggressive medical care and were more likely to receive hospice services for more than one week. Less aggressive care and earlier hospice referrals were associated with better patient QoL near death. Of note, patients who received less than one week of hospice care had the same QoL scores as patients who did not receive hospice at all, suggesting that patients benefit more from early hospice referrals. Better patient QoL near death, in turn, was associated with better QoL among surviving caregivers who experienced less regret and showed improvements in self-reported health, physical functioning, mental health, and overall QoL during the bereavement period.

To date, most of the communications literature in cancer has focused on doctors’ and patients’ preferences surrounding prognostication with little attention paid to the psychological and medical outcomes of these conversations.³⁸ The bereavement literature has begun to explore the associations between patients’ place of death, the receipt of hospice care, and caregivers’ subsequent risk for psychiatric disorders.³⁹^-⁴⁰^,¹⁷ Recent studies have shown that communication interventions in the intensive care unit can reduce psychological distress among bereaved family members.⁴¹ Our results suggest that bereavement-related distress might be offset by interventions aimed at reducing aggressive care.

Our findings must be interpreted within the context of an observational study that could not randomize terminally ill cancer patients to EOL discussions for ethical and logistical reasons. In lieu of a trial, propensity-score weighting enabled us to examine our primary outcome independent of observed differences. Although this technique cannot correct for unmeasured or hidden biases, such as how a patients’ prior experiences with death may influence their attitudes to EOL discussions or decision-making, it is one of the most robust statistical methods available to correct for potential selection bias and confounding. Nevertheless, it is possible that patients who have a preference for less aggressive medical care may be more likely to initiate EOL discussions with their physicians. Alternatively, it is possible that the timing of EOL discussions is important, or that EOL discussions are a proxy for physician factors which may determine medical treatment at the EOL (e.g., physicians who have EOL discussions may limit their patients’ exposure to aggressive medical measures by choosing not to hospitalize patients with terminal illness).

We were further constrained by the limited information available on EOL discussions. For example, we do not know who initiated the conversation, when it happened, or what was said. Our study did not include interviews with doctors or audio-taped conversations. Unfortunately, EOL discussions are often poorly documented in the medical record, and other studies have revealed that patients are caregivers recall of conversations often disagree.⁹ Absent such independent validation, the accuracy of patients’ reported rates of discussions remains unknown, and we suspect our results are a conservative estimate of the true point prevalence of EOL conversations.⁹^,⁴⁶ In addition, it worth noting that our sample had disproportionately high rates of ethnic minority patients who were highly symptomatic and had poor performance statuses. Future research is needed to determine whether these findings generalize to patients who are less debilitated and have higher socio-economic status.

One of the strengths of this study is that it includes well validated structured clinical interviews for the diagnosis of mental disorders. Although there was no evidence that EOL discussions were associated with greater psychological distress, it is possible that results may differ in samples with higher rates of psychiatric morbidity. Because our data were cross-sectional, we cannot make causal inferences about patients’ psychological state at the time of the discussion, or their immediate reactions following it. However, if EOL discussions did evoke substantial psychological distress, we would expect to detect a positive association between the two.

The association between EOL discussions and patients’ preference for less aggressive care is noteworthy. EOL discussions may make patients more realistic about the benefits of aggressive therapies, and thereby reduce the likelihood that they receive intensive treatments near death.¹⁵^,⁴³ In this study, we cannot confirm the direction of this association because we did not examine changes in preferences resulting from EOL discussions.

In this study, more than 60% of dying patients do not recall having EOL discussions with their physicians. Several possible explanations exist. Cancer patients frequently misunderstand or fail to recall prognostic discussions, even when they occur.⁴⁴^-⁴⁷ Physicians also often avoid EOL conversations, communicate euphemistically, are overly optimistic, or delay discussions until patients are close to death, perhaps because their own feelings of failure or loss.⁴^,⁵^,¹⁰^,¹³^,⁴⁸^,⁴⁹ Consistent with this hypothesis, patients with lower Karnofsky scores, higher symptom burdens, and shorter median survivals were more likely to report having EOL conversations. Interestingly, patients’ recall of EOL discussion varied significantly by site, with fewer patients reporting EOL discussions at a major academic center. Future studies are needed to examine factors influencing patient selection of medical centers for care, and whether centers have distinct cultures that dictate the style and content of EOL conversations.

Given the adverse outcomes associated with not having EOL discussions there appears to be a need to increase the frequency of these conversations. By acknowledging that the EOL is near, patients, caregivers, and physicians can focus on clarifying patients’ priorities and improving pain and symptom management.¹^,⁵⁰

Acknowledgment

This research was supported in part by the following grants to Dr. Prigerson: MH63892 from the National Institute of Mental Health and CA 106370 from the National Cancer Institute; the Center for Psycho-Oncology and Palliative Care Research, Dana-Farber Cancer Institute

Funding/Support: This study was supported by the National Cancer Institute under grant CA 106370 and the National Institute of Mental Health under grant MH63892. Preparation of the manuscript was also supported, in part, by the National Cancer Institute under grant CA 92044343 entitled, “Program in Cancer Outcomes Research Training” and the Dana-Farber Cancer Institute’s Friends Fellowship.

Role of the sponsors: The funding organizations had no role in the design and conduct of the study; collection, analysis, or preparation of the data; or preparation, review, or approval of the manuscript.

Footnotes

Disclosure: None of the authors have relationships with any entities having financial interest in this topic.

Conception and design: Wright, Zhang, Prigerson, Ray, Block, Trice, Balboni, Mitchell, Jackson.

Acquisition of data: Prigerson.

Analysis and interpretation of data: Wright, Zhang, Ray, Maciejewski, Prigerson.

Drafting of the manuscript: Wright, Zhang, Prigerson, Trice, Balboni, Mitchell, Mack, Jackson, Block

Critical revision of the manuscript for important intellectual content: Wright, Zhang, Ray, Mack, Block, Trice, Balboni, Mitchell, Jackson, Maciejewski, Prigerson.

Statistical analysis: Wright, Zhang, Ray, Maciejewski, Prigerson.

Obtained funding: Prigerson.

Administrative, technical, or material support: Elizabeth Paulk, Heather Stieglitz, Gail Farrington, Matt Nilsson, Maureen Clark, Dr. Linda Wright and Dr. Ingrid Katz.

Financial disclosures: None.

References

1. Quill TE. Perspectives on care at the close of life. Initiating end-of-life discussions with seriously ill patients: addressing the “elephant in the room” JAMA. 2000;284(19):2502–7. [PubMed]

2. Leydon GM, Boulton M, Moynihan C, et al. Cancer patients’ information needs and information seeking behavior: in depth interview study. BMJ. 2000;320(7239):909–13. [PMC free article] [PubMed]

3. Hagerty RG, Butow PN, Ellis PA, et al. Cancer patient preferences for communication of prognosis in the metastatic setting. J Clin Oncol. 2004;22(9):1721–30. [PubMed]

4. Baile WF, Lenzi R, Parker PA, Buckman R, Cohen L. Oncologists’ attitudes toward and practices in giving bad news: an exploratory study. J Clin Oncol. 2002;20(8):2189–2196. [PubMed]

5. Gordon EJ, Daugherty CK. “Hitting you over the head”: Oncologists’ disclosure of prognosis to advanced cancer patients. Bioethics. 2003;17(2):142–168. [PubMed]

6. Christakis NA. Death Foretold: prophecy and prognosis in medical care. University of Chicago Press; Chicago, IL: 1999.

7. Ptacek JT, Ptacek JJ, Ellison NM. “I’m sorry to tell you…” Physicians’ reports of breaking bad news. J Behav Med. 2001;24(2):205–217. [PubMed]

8. The A, Hak T, Koeter G, van der Wal G. Collusion in doctor-patient communication about imminent death: an ethnographic study. West J Med. 2001;17(4):247–53. [PMC free article] [PubMed]

9. Cherlin E, Fried T, Prigerson HG, Schulman-Green D, Johnson-Hurzeler R, Bradley EH. Communication between physicians and family caregivers about care at the end of life: when do discussions occur and what is said? J Palliat Med. 2005;8(6):1176–85. [PMC free article] [PubMed]

10. Helft PR. Necessary collusion: Prognostic communication with advanced cancer patients. J Clin Oncol. 2005;23(13):3146–3150. [PubMed]

11. Lamont EB, Siegler M. Paradoxes in cancer patients’ advance care planning. J Palliat Med. 2000;3(1):27–35. [PubMed]

12. Selman L, Harding R, Beynon T, et al. Improving end-of-life-care for patients with chronic heart failure: “Let’s hope it’ll get better, when I know in my heart of hearts it won’t.” Heart. 2007;93(8):963–7. [PMC free article] [PubMed]

13. Meier DE, Back AL, Morrison RS. The inner life of physicians and care of the seriously ill. JAMA. 2001;286(23):3007–14. [PubMed]

14. Weeks JC, Cook EF, O’Day SJ, et al. Relationship between cancer patients’ predictions of prognosis and their treatment preferences. JAMA. 1998;279(21):1709–14. [PubMed]

15. Prigerson HG. Socialization to dying: social determinants of death acknowledgment and treatment among terminally ill geriatric patients. J Health Soc Behav. 1992;33(4):378–395. [PubMed]

16. Hofmann JC, Wenger NS, Davis RB, et al. Patient preferences for communication with physicians about end-of-life decisions. Ann Intern Med. 1997;127(1):1–12. [PubMed]

17. Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291(1):88–93. [PubMed]

18. Kris AE, Cherlin EJ, Prigerson H, et al. Length of hospice enrollment and subsequent depression in family caregivers: 13-month follow-up study. Am J Geriatr Psychiatry. 2006;14(3):264–9. [PubMed]

19. Chu KC, Miller BA, Springfield SA. Measures of racial/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status. J Natl Med Assoc. 2007;(10):1092–100. 1102–4. [PMC free article] [PubMed]

20. Albano JD, Ward E, Jemal A, Anderson R, Cokkinides VE, Murray T, Henley J, Liff J, Thun MJ. Cancer mortality in the United States by education level and race. J Natl Cancer Inst. 2007;(18):1384–94. [PubMed]

21. Ray A, Block SD, Friedlander RJ, Zhang B, Maciejewski PK, Prigerson HG. Peaceful awareness in patients with advanced cancer. J Palliat Med. 2006;9(6):1359–68. [PubMed]

22. Balboni TA, Vanderwerker LC, Block SD, et al. Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of life. J Clin Oncol. 2007;25(5):555–60. [PMC free article] [PubMed]

23. Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA. 2000;284(19):2476–82. [PubMed]

24. Caralis PV, Davis B, Wright K, Marcial E. The influence of ethnicity and race on attitudes toward advance directives, life-prolonging treatments, and euthanasia. J Clin Ethics. 1993;4:155–65. [PubMed]

25. Crawley L, Payne R, Bolden J, Payne T, Washington P, Williams S. Palliative and end-of-life care in the African American community. JAMA. 2000;284:2518–21. [PubMed]

26. Trice ED, Paulk E, Nilsson M, Wright AA, Balboni T, Viswanath K, Emmons K, Stieglitz H, DeSanto-Madeya S, Prigerson HG. Understanding the role of ethnic status in Intensive Care Unit (ICU) deaths among advanced cancer patients. J Clin Oncol. 2008 May 20;26(suppl) abstr 6506.

27. Gessert CE, Curry NM, Robinson A. Ethnicity and end-of-life care: the use of feeding tubes. Ethn Dis. 2001;11:97–106. [PubMed]

28. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for the DSM-IV Axis I Disorders – Patient Edition (SCID-I/P) version 2.0. New York State Psychiatric Institute; New York: 1995.

29. Williams JB, Gibbon M, First MB, et al. The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry. 1992;49(8):630–6. [PubMed]

30. Endicott J. Measurement of depression in patients with cancer. Cancer. 1984;53(10 Suppl):2243–9. [PubMed]

31. Cohen SR, Mount BM, Bruera E, Provost M, Rowe J, Tong K. Validity of the McGill Quality of Life Questionnaire in the palliative care setting: a multi-centre Canadian study demonstrating the importance of the existential domain. Palliat Med. 1997;11(1):3–20. [PubMed]

32. Karnofsky D, Abelmann W, Craver L, Burchenal J. The use of nitrogen mustard in the palliative treatment of cancer. Cancer. 1948;1:634–656.32.

33. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. [PubMed]

34. McHorney CA, Ware JE, Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31(3):247–63.34. [PubMed]

35. Earle CC, Neville BA, Landrum MB, Ayanian JZ, Block SD, Weeks JC. Trends in the aggressiveness of cancer care near the end of life. J Clin Oncol. 2004;22(2):315–21. [PubMed]

36. Maciejewski PK, Zhang B, Block SD, Prigerson HG. An empirical examination of the stage theory of grief. JAMA. 2007;297(7):716–23. [PubMed]

37. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516–24.

38. Hancock K, Clayton JM, Parker SM, et al. Truth-telling in discussing prognosis in advanced life-limiting illnesses: a systematic review. Palliat Med. 2007;21(6):507–17. [PubMed]

39. Azoulay E, Pochard F, Kentish-Barnes N, et al. Risk of post-traumatic stress symptoms in family members of intensive care unit patients. Am J Respir Crit Care Med. 2005;171(9):987–94. [PubMed]

40. Siegel MD, Hayes E, Vanderwerker LC, Loseth DB, Prigerson HG. Psychiatric illness in the next of kin of patients who die in the intensive care unit. Crit Care Med. 2008;36(6):1–7. [PubMed]

41. Lautrette A, Darmon M, Megarbane B, et al. A communication strategy and brochure for relatives of patients dying in the ICU. N Engl J Med. 2007;356(5):469–78. [PubMed]

42. Rady MY, Johnson DJ. Admission to intensive care unit at the end-of-life: is it an informed decision? Palliat Med. 2004;18(8):705–11. [PubMed]

43. Mack JW, Nilsson M, Balboni T, Friedlander RJ, Block SD, Trice E, Prigerson HG. Peace, Equanimity, and Acceptance in the cancer experience (PEACE): validation of a scale to assess acceptance and struggle with terminal illness. Cancer. 2008 Jun 1;112(11):2509–17. [PubMed]

44. Hagerty RG, Butow PN, Ellis PM, et al. Communicating with realism and hope: incurable cancer patients’ views on the disclosure of prognosis. J Clin Oncol. 2005;23(9):1278–88. [PubMed]

45. Eidinger RN, Schapira DV. Cancer patients’ insight into their treatment, prognosis, and unconventional therapies. Cancer. 1984;53(12):2736–2740. [PubMed]

46. Lehmann L, Shaykevich S, Weeks JC. Communication and understanding of prognosis among stage IV lung and GI cancer patients. J Clin Oncol; 2007 ASCO Annual Meeting Proceedings Part I.2007. p. 9024.

47. Fried TR, Bradley EH, O’Leary J. Prognosis communication in serious illness: perceptions of older patients, caregivers, and clinicians. J Am Geriatr Soc. 2003;51(10):1398–403. [PubMed]

48. Sullivan AM, Lakoma MD, Matsuyama RK, et al. Diagnosing and discussing imminent death in the hospital: a secondary analysis of physician interviews. J Palliat Med. 2007 Aug;10(4):882–93. [PubMed]

49. Harrington SE, Smith TJ. The role of chemotherapy at the end of life: “when is enough, enough?” JAMA. 2008;299(22):2667–78. [PMC free article] [PubMed]

50. Back AL, Arnold RM, Quill TE. Hope for the best, and prepare for the worst. Ann Intern Med. 2003;138:439–43. [PubMed]